ID IL22_HUMAN Reviewed; 179 AA. AC Q9GZX6; DT 16-NOV-2001, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2001, sequence version 1. DT 27-MAR-2024, entry version 190. DE RecName: Full=Interleukin-22; DE Short=IL-22; DE AltName: Full=Cytokine Zcyto18; DE AltName: Full=IL-10-related T-cell-derived-inducible factor; DE Short=IL-TIF; DE Flags: Precursor; GN Name=IL22; Synonyms=ILTIF, ZCYTO18; ORFNames=UNQ3099/PRO10096; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=10954742; DOI=10.1073/pnas.170291697; RA Dumoutier L., Van Roost E., Colau D., Renauld J.-C.; RT "Human interleukin-10-related T cell-derived inducible factor: molecular RT cloning and functional characterization as an hepatocyte-stimulating RT factor."; RL Proc. Natl. Acad. Sci. U.S.A. 97:10144-10149(2000). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=11197690; DOI=10.1038/sj.gene.6363716; RA Dumoutier L., Van Roost E., Colau D., Ameye G., Michaux L., Renauld J.-C.; RT "IL-TIF/IL-22: genomic organization and mapping of the human and mouse RT genes."; RL Genes Immun. 1:488-494(2000). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION. RX PubMed=10875937; DOI=10.1074/jbc.m005304200; RA Xie M.-H., Aggarwal S., Ho W.-H., Foster J., Zhang Z., Stinson J., RA Wood W.I., Goddard A.D., Gurney A.L.; RT "Interleukin (IL)-22, a novel human cytokine that signals through the RT interferon receptor-related proteins CRF2-4 and IL-22R."; RL J. Biol. Chem. 275:31335-31339(2000). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=12975309; DOI=10.1101/gr.1293003; RA Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., RA Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., RA Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A., RA Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., RA Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., RA Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., RA Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., RA Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.; RT "The secreted protein discovery initiative (SPDI), a large-scale effort to RT identify novel human secreted and transmembrane proteins: a bioinformatics RT assessment."; RL Genome Res. 13:2265-2270(2003). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLY-158. RG SeattleSNPs variation discovery resource; RL Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Blood; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP PROTEIN SEQUENCE OF 34-48. RX PubMed=15340161; DOI=10.1110/ps.04682504; RA Zhang Z., Henzel W.J.; RT "Signal peptide prediction based on analysis of experimentally verified RT cleavage sites."; RL Protein Sci. 13:2819-2824(2004). RN [8] RP FUNCTION. RX PubMed=17204547; DOI=10.1152/ajpgi.00239.2006; RA Brand S., Dambacher J., Beigel F., Zitzmann K., Heeg M.H.J., Weiss T.S., RA Pruefer T., Olszak T., Steib C.J., Storr M., Goeke B., Diepolder H., RA Bilzer M., Thasler W.E., Auernhammer C.J.; RT "IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 RT overexpression in vitro."; RL Am. J. Physiol. 292:G1019-G1028(2007). RN [9] RP FUNCTION. RX PubMed=25793261; DOI=10.1371/journal.pone.0119872; RA Akil H., Abbaci A., Lalloue F., Bessette B., Costes L.M., Domballe L., RA Charreau S., Guilloteau K., Karayan-Tapon L., Bernard F.X., Morel F., RA Jauberteau M.O., Lecron J.C.; RT "IL22/IL-22R pathway induces cell survival in human glioblastoma cells."; RL PLoS ONE 10:e0119872-e0119872(2015). RN [10] RP FUNCTION. RX PubMed=31311100; DOI=10.3390/ijms20143468; RA Moniruzzaman M., Wang R., Jeet V., McGuckin M.A., Hasnain S.Z.; RT "Interleukin (IL)-22 from IL-20 Subfamily of Cytokines Induces Colonic RT Epithelial Cell Proliferation Predominantly through ERK1/2 Pathway."; RL Int. J. Mol. Sci. 20:0-0(2019). RN [11] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 29-179. RX PubMed=11856845; DOI=10.1107/s0907444902001063; RA Nagem R.A., Lucchesi K.W., Colau D., Dumoutier L., Renauld J.-C., RA Polikarpov I.; RT "Crystallization and synchrotron X-ray diffraction studies of human RT interleukin-22."; RL Acta Crystallogr. D 58:529-530(2002). RN [12] RP X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 38-179, AND GLYCOSYLATION AT RP ASN-54 AND ASN-97. RX PubMed=15983417; DOI=10.1107/s0907444905009601; RA Xu T., Logsdon N.J., Walter M.R.; RT "Structure of insect-cell-derived IL-22."; RL Acta Crystallogr. D 61:942-950(2005). RN [13] RP X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 39-179 IN COMPLEX WITH IL22RA1, RP DISULFIDE BONDS, AND FUNCTION. RX PubMed=18599299; DOI=10.1016/j.str.2008.06.005; RA Jones B.C., Logsdon N.J., Walter M.R.; RT "Structure of IL-22 bound to its high-affinity IL-22R1 chain."; RL Structure 16:1333-1344(2008). CC -!- FUNCTION: Cytokine that plays a critical role in modulating tissue CC responses during inflammation (PubMed:17204547). Plays an essential CC role in the regeneration of epithelial cells to maintain barrier CC function after injury and for the prevention of further tissue damage CC (PubMed:17204547). Unlike most of the cytokines, has no effect on CC immune cells. Signals through a heterodimeric receptor composed of two CC subunits, the specific receptor IL22RA1 which is present on non-immune CC cells in many organs and the shared subunit IL10RB (PubMed:10875937, CC PubMed:18599299). Ligation of IL22RA1 with IL22 induces activation of CC the tyrosine kinases JAK1 and TYK2, which in turn activates STAT3. In CC turn, promotes cell survival and proliferation through STAT3, ERK1/2 CC and PI3K/AKT pathways (PubMed:25793261, PubMed:31311100). Promotes CC phosphorylation of GSK3B at 'Ser-9' and CTTN (By similarity). Promotes CC epithelial cell spreading (By similarity). CC {ECO:0000250|UniProtKB:Q9JJY9, ECO:0000269|PubMed:10875937, CC ECO:0000269|PubMed:17204547, ECO:0000269|PubMed:18599299, CC ECO:0000269|PubMed:25793261, ECO:0000269|PubMed:31311100}. CC -!- INTERACTION: CC Q9GZX6; Q08334: IL10RB; NbExp=2; IntAct=EBI-8040250, EBI-11175900; CC Q9GZX6; Q8N6P7: IL22RA1; NbExp=9; IntAct=EBI-8040250, EBI-3940749; CC PRO_0000015383; Q8N6P7: IL22RA1; NbExp=4; IntAct=EBI-11315863, EBI-3940749; CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- SIMILARITY: Belongs to the IL-10 family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=SeattleSNPs; CC URL="http://pga.gs.washington.edu/data/il22/"; CC -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and CC Haematology; CC URL="https://atlasgeneticsoncology.org/gene/44519/IL22"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ277247; CAC06085.1; -; mRNA. DR EMBL; AJ277248; CAC19409.1; -; Genomic_DNA. DR EMBL; AF279437; AAG22064.1; -; mRNA. DR EMBL; AY358890; AAQ89249.1; -; mRNA. DR EMBL; AF387519; AAK62468.1; -; Genomic_DNA. DR EMBL; BC066263; AAH66263.1; -; mRNA. DR EMBL; BC067510; AAH67510.1; -; mRNA. DR EMBL; BC069112; AAH69112.1; -; mRNA. DR EMBL; BC069308; AAH69308.1; -; mRNA. DR EMBL; BC070261; AAH70261.1; -; mRNA. DR CCDS; CCDS8982.1; -. DR RefSeq; NP_065386.1; NM_020525.4. DR PDB; 1M4R; X-ray; 2.00 A; A/B=29-179. DR PDB; 1YKB; X-ray; 2.60 A; A/B/C/D/E/F=38-179. DR PDB; 3DGC; X-ray; 2.50 A; L/M=39-179. DR PDB; 3DLQ; X-ray; 1.90 A; I=29-179. DR PDB; 3G9V; X-ray; 2.76 A; B/D=29-179. DR PDB; 3Q1S; X-ray; 2.15 A; I=29-179. DR PDBsum; 1M4R; -. DR PDBsum; 1YKB; -. DR PDBsum; 3DGC; -. DR PDBsum; 3DLQ; -. DR PDBsum; 3G9V; -. DR PDBsum; 3Q1S; -. DR AlphaFoldDB; Q9GZX6; -. DR SMR; Q9GZX6; -. DR BioGRID; 119096; 8. DR DIP; DIP-46035N; -. DR IntAct; Q9GZX6; 3. DR MINT; Q9GZX6; -. DR STRING; 9606.ENSP00000442424; -. DR BindingDB; Q9GZX6; -. DR ChEMBL; CHEMBL3712915; -. DR GlyCosmos; Q9GZX6; 3 sites, No reported glycans. DR GlyGen; Q9GZX6; 3 sites. DR iPTMnet; Q9GZX6; -. DR PhosphoSitePlus; Q9GZX6; -. DR BioMuta; IL22; -. DR DMDM; 17366814; -. DR jPOST; Q9GZX6; -. DR MassIVE; Q9GZX6; -. DR PaxDb; 9606-ENSP00000442424; -. DR PeptideAtlas; Q9GZX6; -. DR ProteomicsDB; 80167; -. DR ABCD; Q9GZX6; 35 sequenced antibodies. DR Antibodypedia; 16687; 1038 antibodies from 43 providers. DR DNASU; 50616; -. DR Ensembl; ENST00000328087.6; ENSP00000329384.4; ENSG00000127318.11. DR Ensembl; ENST00000538666.6; ENSP00000442424.1; ENSG00000127318.11. DR GeneID; 50616; -. DR KEGG; hsa:50616; -. DR MANE-Select; ENST00000538666.6; ENSP00000442424.1; NM_020525.5; NP_065386.1. DR UCSC; uc001sty.2; human. DR AGR; HGNC:14900; -. DR CTD; 50616; -. DR DisGeNET; 50616; -. DR GeneCards; IL22; -. DR HGNC; HGNC:14900; IL22. DR HPA; ENSG00000127318; Tissue enhanced (urinary). DR MIM; 605330; gene. DR neXtProt; NX_Q9GZX6; -. DR OpenTargets; ENSG00000127318; -. DR PharmGKB; PA29822; -. DR VEuPathDB; HostDB:ENSG00000127318; -. DR eggNOG; ENOG502S5PC; Eukaryota. DR GeneTree; ENSGT00510000048550; -. DR HOGENOM; CLU_127397_0_0_1; -. DR InParanoid; Q9GZX6; -. DR OMA; INFQQPY; -. DR OrthoDB; 5322174at2759; -. DR PhylomeDB; Q9GZX6; -. DR TreeFam; TF333253; -. DR PathwayCommons; Q9GZX6; -. DR Reactome; R-HSA-8854691; Interleukin-20 family signaling. DR SignaLink; Q9GZX6; -. DR SIGNOR; Q9GZX6; -. DR BioGRID-ORCS; 50616; 10 hits in 1136 CRISPR screens. DR ChiTaRS; IL22; human. DR EvolutionaryTrace; Q9GZX6; -. DR GeneWiki; Interleukin_22; -. DR GenomeRNAi; 50616; -. DR Pharos; Q9GZX6; Tbio. DR PRO; PR:Q9GZX6; -. DR Proteomes; UP000005640; Chromosome 12. DR RNAct; Q9GZX6; Protein. DR Bgee; ENSG00000127318; Expressed in vermiform appendix and 57 other cell types or tissues. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; ISS:UniProt. DR GO; GO:0005125; F:cytokine activity; ISS:UniProt. DR GO; GO:0045518; F:interleukin-22 receptor binding; NAS:UniProtKB. DR GO; GO:0006953; P:acute-phase response; NAS:UniProtKB. DR GO; GO:0006954; P:inflammatory response; NAS:UniProtKB. DR GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProt. DR GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl. DR Gene3D; 1.20.1250.10; -; 1. DR InterPro; IPR009079; 4_helix_cytokine-like_core. DR InterPro; IPR020423; IL-10_CS. DR InterPro; IPR020453; IL-22. DR PANTHER; PTHR48400; INTERLEUKIN-22; 1. DR PANTHER; PTHR48400:SF1; INTERLEUKIN-22; 1. DR Pfam; PF14565; IL22; 1. DR PIRSF; PIRSF037726; Interleukin-22; 1. DR PRINTS; PR01936; INTRLEUKIN22. DR SUPFAM; SSF47266; 4-helical cytokines; 1. DR PROSITE; PS00520; INTERLEUKIN_10; 1. DR Genevisible; Q9GZX6; HS. PE 1: Evidence at protein level; KW 3D-structure; Cytokine; Direct protein sequencing; Disulfide bond; KW Glycoprotein; Reference proteome; Secreted; Signal. FT SIGNAL 1..33 FT /evidence="ECO:0000269|PubMed:15340161" FT CHAIN 34..179 FT /note="Interleukin-22" FT /id="PRO_0000015383" FT CARBOHYD 54 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:15983417" FT CARBOHYD 68 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 97 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:15983417" FT DISULFID 40..132 FT /evidence="ECO:0000269|PubMed:18599299" FT DISULFID 89..178 FT /evidence="ECO:0000269|PubMed:18599299" FT VARIANT 158 FT /note="S -> G (in dbSNP:rs2227507)" FT /evidence="ECO:0000269|Ref.5" FT /id="VAR_013078" FT HELIX 44..47 FT /evidence="ECO:0007829|PDB:3DLQ" FT HELIX 50..65 FT /evidence="ECO:0007829|PDB:3DLQ" FT STRAND 74..76 FT /evidence="ECO:0007829|PDB:1M4R" FT HELIX 77..80 FT /evidence="ECO:0007829|PDB:3DLQ" FT HELIX 85..87 FT /evidence="ECO:0007829|PDB:3DLQ" FT HELIX 88..102 FT /evidence="ECO:0007829|PDB:3DLQ" FT TURN 103..109 FT /evidence="ECO:0007829|PDB:3DLQ" FT HELIX 114..129 FT /evidence="ECO:0007829|PDB:3DLQ" FT HELIX 141..155 FT /evidence="ECO:0007829|PDB:3DLQ" FT HELIX 157..165 FT /evidence="ECO:0007829|PDB:3DLQ" FT HELIX 167..178 FT /evidence="ECO:0007829|PDB:3DLQ" SQ SEQUENCE 179 AA; 20011 MW; 3C35E64D60CF8767 CRC64; MAALQKSVSS FLMGTLATSC LLLLALLVQG GAAAPISSHC RLDKSNFQQP YITNRTFMLA KEASLADNNT DVRLIGEKLF HGVSMSERCY LMKQVLNFTL EEVLFPQSDR FQPYMQEVVP FLARLSNRLS TCHIEGDDLH IQRNVQKLKD TVKKLGESGE IKAIGELDLL FMSLRNACI //